StockWatch
·

TITAN BIOTECH LTD. Q1 FY27 Results

TITANBIOQ1 FY27 Results
Filing
Result:Very Good· Market: Up#Broad based#Margin expansion
MetricValue ( Cr)Q4 FY26Q1 FY26
Revenue59.1721.2%27.3%
Total Income60.9819.7%29.1%
Expenditure48.2418.7%23.4%
PBT12.7323.9%57.0%
Net Profit10.8661.3%58.2%
OPM21.11%1.23pp2.32pp
NPM17.80%4.59pp3.27pp
EPS2.6361.4%68.3%
View full financials

Revenue up 27.2% YoY with PAT up 58.2%, driven by core-business margin expansion (OPM 18.8%→21.1%, NPM 14.5%→17.8%) rather than one-offs, a standout quarter for a chemicals manufacturer.

Informational and educational content only. Not investment advice.